DGAT-2 inhibitor - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Almonty Industries prices $700m notes as $AII investors assess tungsten expansion funding

K. Annamalai exits BJP as TN politics enters new realignment phase

Representative image of a Wall Street market selloff as stronger jobs data fuels Federal Reserve rate fears and triggers a sharp AI chip stock rout.

Good news, bad market: how 172,000 jobs triggered the worst chip day since 2020

Representative image of a packed football stadium during a major international match, highlighting how FIFA World Cup 2026 will bring together 48 teams, 16 host cities and global fan demand across the United States, Canada and Mexico

FIFA World Cup 2026 groups explained: Which teams are in each group and what are the biggest early storylines?

Read More

Pharma Industry News

Madrigal Pharmaceuticals adds Phase 2 DGAT-2 inhibitor ervogastat to MASH pipeline under global licensing agreement

Find out how Madrigal Pharmaceuticals is expanding its MASH strategy with a global license for ervogastat, a Phase 2 DGAT-2 inhibitor.

bySoujanya Ravi

January 12, 2026

web analytics